Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

The Faculty of Medicine - Microbiology and Molecular Genetics: Engelberg-Kulka Hanna


 Last updated June 2021 - School of Pharmacy

List of Publications

(1) Itin C, Domb AJ, Hoffman A. On the Suitability of Porcine Labial Mucosa as a Model for Buccal Mucosal Drug Delivery Research. J Pharm Sci 2021;110(4):1863-1864.

(2) Itin C, Komargodski R, Barasch D, Domb AJ, Hoffman A. Prolonged Delivery of Apomorphine Through the Buccal Mucosa, Towards a Noninvasive Sustained Administration Method in Parkinson's Disease: In Vivo Investigations in Pigs. J Pharm Sci 2021;110(4):1824-1833.

(3) Rakedzon S, Neuberger A, Domb AJ, Petersiel N, Schwartz E. From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2? J Travel Med 2021;28(2).

(4) Nahum V, Domb AJ. Recent developments in solid lipid microparticles for food ingredients delivery. Foods 2021;10(2):1-25.

(5) Arun Y, Daifa M, Domb AJ. Polyhydroxamic acid as an efficient metal chelator and flocculant for wastewater treatment. Polym Adv Technol 2021;32(2):842-852.

(6) Duo X, Bai L, Wang J, Guo J, Ren X, Xia S, et al. Erratum to: Multifunctional peptide conjugated amphiphilic cationic copolymer for enhancing ECs targeting, penetrating and nuclear accumulation (Frontiers of Chemical Science and Engineering, (2020), 14, 5, (889-901), 10.1007/s11705-020-1919-8). Front Chem Sci Eng 2021;15(1):220.

(7) Arun Y, Ghosh R, Domb AJ. Biodegradable Hydrophobic Injectable Polymers for Drug Delivery and Regenerative Medicine. Adv Funct Mater 2021.

(8) Ramot Y, Steiner M, Amouyal N, Lavie Y, Klaiman G, Domb AJ, et al. Treatment of contaminated radial fracture in sprague-dawley rats by application of a degradable polymer releasing gentamicin. J Toxicol Pathol 2021;34(1):11-22.

(9) Basu A, Domb AJ. Ion Exchange Nanoparticles for Ophthalmic Drug Delivery. Bioconjugate Chem 2020;31(12):2726-2736.

(10) Haim Zada M, Gallimidi Z, Schlesinger-Laufer M, Nyska A, Domb AJ. Biodegradable Breast Tissue Marker Clip. ACS Appl Bio Mater 2020;3(11):7439-7453.

(11) Steinman NY, Bentolila NY, Domb AJ. Effect of molecular weight on gelling and viscoelastic properties of poly(Caprolactone)–b‐ poly(ethylene glycol)–b‐poly(caprolactone) (PCL– PEG–PCL) hydrogels. Polym 2020;12(10):1-12.

(12) Duo X, Bai L, Wang J, Guo J, Ren X, Xia S, et al. Multifunctional peptide conjugated amphiphilic cationic copolymer for enhancing ECs targeting, penetrating and nuclear accumulation. Front Chem Sci Eng 2020;14(5):889-901.

(13) Itin C, Komargodski R, Domb AJ, Hoffman A. Controlled Delivery of Apomorphine Through Buccal Mucosa, Towards a Noninvasive Administration Method in Parkinson's Disease: A Preclinical Mechanistic Study. J Pharm Sci 2020;109(9):2729-2734.

(14) Belay C, Steinman NY, Campos LM, Dzikowski R, Golenser J, Domb AJ. Asymmetric trisalkylamine cyclopropenium derivatives with antimicrobial activity. Bioorg Chem 2020;102.

(15) Izgelov D, Davidson E, Barasch D, Regev A, Domb AJ, Hoffman A. Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers. Eur J Pharm Biopharm 2020;154:108-115.

(16) Steinman NY, Campos LM, Feng Y, Domb AJ, Hosseinkhani H. Cyclopropenium nanoparticles and gene transfection in cells. Pharmaceutics 2020;12(8):1-12.

(17) Golenser J, Salaymeh N, Higazi AA, Alyan M, Daif M, Dzikowski R, et al. Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation. Front Pharmacol 2020;11.

(18) Izgelov D, Regev A, Domb AJ, Hoffman A. Using the Absorption Cocktail Approach to Assess Differential Absorption Kinetics of Cannabidiol Administered in Lipid-Based Vehicles in Rats. Mol Pharm 2020;17(6):1979-1986.

(19) Kommineni N, Pandi P, Chella N, Domb AJ, Khan W. Antibody drug conjugates: Development, characterization, and regulatory considerations. Polym Adv Technol 2020;31(6):1177-1193.

(20) Izgelov D, Domb AJ, Hoffman A. The effect of piperine on oral absorption of cannabidiol following acute vs. chronic administration. Eur J Pharm Sci 2020;148.

(21) Itin C, Barasch D, Domb AJ, Hoffman A. Prolonged oral transmucosal delivery of highly lipophilic drug cannabidiol. Int J Pharm 2020;581.

(22) Izgelov D, Shmoeli E, Domb AJ, Hoffman A. The effect of medium chain and long chain triglycerides incorporated in self-nano emulsifying drug delivery systems on oral absorption of cannabinoids in rats. Int J Pharm 2020;580.

(23) Haim Zada M, Kumar A, Elmalak O, Markovitz E, Icekson R, Domb AJ. In vitro and in vivo degradation behavior and the long-term performance of biodegradable PLCL balloon implants. Int J Pharm 2020;574:118870.

(24) Manoukian OS, Baker JT, Rudraiah S, Arul MR, Vella AT, Domb AJ, et al. Functional polymeric nerve guidance conduits and drug delivery strategies for peripheral nerve repair and regeneration. J Control Release 2020;317:78-95.

(25) Doppalapudi S, Jain A, Khan W, Domb AJ. Fenoldopam mesylate for treating psoriasis: A new indication for an old drug. Int J Pharm 2020;573.

(26) Sarda SR, Tekale SU, Kótai L, Domb AJ, Pawar RP. COVID-19: A global pandemic. Eur Chem Bul 2020;9(8):266-272.

(27) Haim Zada M, Kumar A, Elmalak O, Mechrez G, Domb AJ. Effect of Ethylene Oxide and Gamma (γ-) Sterilization on the Properties of a PLCL Polymer Material in Balloon Implants. ACS Omega 2019;4(25):21319-21326.

(28) Haim Zada M, Kumar A, Elmalak O, Markovitz E, Icekson R, Machlev E, et al. Biodegradable implantable balloons: Mechanical stability under physiological conditions. J Mech Behav Biomed Mater 2019;100.

(29) Zada MH, Goldberg SN, Nissenbaum Y, Domb AJ, Ben-David E. Injectable Biodegradable Multimodal Mammography Marker. ACS Appl Bio Mater 2019;2(11):5069-5076.

(30) Keren A, Gilhar A, Ullmann Y, Zlotkin-Frušić M, Soroka Y, Domb AJ, et al. Instantaneous depolarization of T cells via dopamine receptors, and inhibition of activated T cells of Psoriasis patients and inflamed human skin, by D1-like receptor agonist: Fenoldopam. Immunology 2019;158(3):171-193.

(31) Itin C, Domb AJ, Hoffman A. A meta-opinion: cannabinoids delivered to oral mucosa by a spray for systemic absorption are rather ingested into gastro-intestinal tract: the influences of fed / fasting states. Expert Opin Drug Deliv 2019;16(10):1031-1035.

(32) Domb A. Functional polymers for human health. Polym Adv Technol 2019;30(10):2492.

(33) Hosseinkhani H, Domb AJ. Biodegradable polymers in gene-silencing technology. Polym Adv Technol 2019;30(10):2647-2655.

(34) Daifa M, Shmoeli E, Domb AJ. Enhanced flocculation activity of polyacrylamide-based flocculant for purification of industrial wastewater. Polym Adv Technol 2019;30(10):2636-2646.

(35) Kompella UB, Domb A, Urtti A, Jayagopal A, Wilson CG, Tang-Liu D. ISOPT Clinical Hot Topic Panel Discussion on Ocular Drug Delivery. J Ocul Pharmacol Ther 2019;35(8):457-465.

(36) SreeHarsha N, Hiremath JG, Aitha RK, Domb AJ, Al-Dhubiab BE, Ramnarayanan C, et al. Paclitaxel loaded poly (DL lactic acid co castor oil) 60:40 with poloxamer-F68 rod shape cylindrical nanoparticle preparation and in vitro cytotoxicity studies. Polym Adv Technol 2019;30(10):2613-2622.

(37) Abtew E, Ezra AF, Basu A, Domb AJ. Biodegradable Poly(Acetonide Gluconic Acid) for Controlled Drug Delivery. Biomacromolecules 2019;20(8):2934-2941.

(38) Kasem H, Shriki H, Ganon L, Mizrahi M, Abd-Rbo K, Domb AJ. Rubber plunger surface texturing for friction reduction in medical syringes. Friction 2019;7(4):351-358.

(39) Steinman NY, Starr RL, Brucks SD, Belay C, Meir R, Golenser J, et al. Cyclopropenium-Based Biodegradable Polymers. Macromolecules 2019;52(9):3543-3550.

(40) Kommineni N, Mahira S, Domb AJ, Khan W. Cabazitaxel-loaded nanocarriers for cancer therapy with reduced side effects. Pharmaceutics 2019;11(3):1-22.

(41) Zada MH, Kubek M, Khan W, Kumar A, Domb A. Dispersible hydrolytically sensitive nanoparticles for nasal delivery of thyrotropin releasing hormone (TRH). J Control Release 2019;295:278-289.

(42) Shapira-Furman T, Serra R, Gorelick N, Doglioli M, Tagliaferri V, Cecia A, et al. Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer. J Control Release 2019;295:93-101.

(43) Rathi S, Saka R, Domb AJ, Khan W. Protein-based bioadhesives and bioglues. Polym Adv Technol 2019;30(2):217-234.

(44) Steinman NY, Domb AJ. Injectable pasty biodegradable polyesters derived from castor oil and hydroxyl-acid lactones. J Pharmacol Exp Ther 2019;370(3):736-741.

(45) Bulbake U, Singh A, Domb AJ, Khan W. Therapeutic macromolecular iron chelators. Curr Med Chem 2019;26(2):323-334.

(46) Steinman NY, Haim-Zada M, Goldstein IA, Goldberg AH, Haber T, Berlin JM, et al. Effect of PLGA block molecular weight on gelling temperature of PLGA-PEG-PLGA thermoresponsive copolymers. J Polym Sci Part A 2019;57(1):35-39.

(47) Khan W, Abtew E, Modani S, Domb AJ. Polysaccharide Based Nanoparticles. Isr J Chem 2018;58(12):1315-1329.

(48) Brucks SD, Steinman NY, Starr RL, Domb AJ, Campos LM. Crosslinked colloids with cyclopropenium cations. J Polym Sci Part A 2018;56(23):2641-2645.

(49) Basu A, Domb AJ. Recent Advances in Polyanhydride Based Biomaterials. Adv Mater 2018;30(41).

(50) Abedini F, Ebrahimi M, Roozbehani AH, Domb AJ, Hosseinkhani H. Overview on natural hydrophilic polysaccharide polymers in drug delivery. Polym Adv Technol 2018;29(10):2564-2573.

(51) Kommineni N, Saka R, Khan W, Domb AJ. Non-polymer drug-eluting coronary stents. Drug Deliv Transl Res 2018;8(4):903-917.

(52) Popilski H, Abtew E, Schwendeman S, Domb A, Stepensky D. Efficacy of paclitaxel/dexamethasone intra-tumoral delivery in treating orthotopic mouse breast cancer. J Control Release 2018;279:1-7.

(53) Atsmon J, Cherniakov I, Izgelov D, Hoffman A, Domb AJ, Deutsch L, et al. PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers. J Pharm Sci 2018;107(5):1423-1429.

(54) Izgelov D, Cherniakov I, Aldouby Bier G, Domb AJ, Hoffman A. The Effect of Piperine Pro-Nano Lipospheres on Direct Intestinal Phase II Metabolism: The Raloxifene Paradigm of Enhanced Oral Bioavailability. Mol Pharm 2018;15(4):1548-1555.

(55) Farah S, Domb AJ. Crystalline paclitaxel coated DES with bioactive protective layer development. J Control Release 2018;271:107-117.

(56) Shadmon H, Basu A, Eckhard LH, Domb AJ, Beyth N. Synthesis, characterization and antibacterial activity of heterocyclic quaternary ammonium polymers. New J Chem 2018;42(18):15427-15435.

(57) Beyth N, Yudovin-Farber I, Basu A, Weiss EI, Domb AJ. Antimicrobial nanoparticles in restorative composites. Emerging Nanotechnologies in Dentistry: Second Edition; 2018. p. 41-58.

(58) Cherniakov I, Izgelov D, Barasch D, Davidson E, Domb AJ, Hoffman A. Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration. J Control Release 2017;266:1-7.

(59) Cherniakov I, Izgelov D, Domb AJ, Hoffman A. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model. Eur J Pharm Sci 2017;109:21-30.

(60) Aviv O, Ratner S, Amir N, Laout N, Basu A, Shadmon H, et al. Cationic antimicrobial copolymer poly (methylmethacrylate-co-PHMG) decontaminates water. Polym Adv Technol 2017;28(10):1334-1338.

(61) Abtew E, Domb AJ, Basu A. Synthesis of glycopeptides from glucosaminic acid. J Polym Sci Part A 2017;55(16):2657-2662.

(62) Basu A, Nazarkovsky M, Ghadi R, Khan W, Domb AJ. Poly(lactic acid)-based nanocomposites. Polym Adv Technol 2017;28(8):919-930.

(63) Gold D, Alian M, Domb A, Karawani Y, Jbarien M, Chollet J, et al. Elimination of Schistosoma mansoni in infected mice by slow release of artemisone. Int J Parasitol Drugs Drug Resist 2017;7(2):241-247.

(64) Haim-Zada M, Basu A, Hagigit T, Schlinger R, Grishko M, Kraminsky A, et al. Stable polyanhydride synthesized from sebacic acid and ricinoleic acid. J Control Release 2017;257:156-162.

(65) Kagan S, Ickowicz DE, Domb AJ, Dagan A, Polacheck I. Unique aggregation of conjugated amphotericin B and its interaction with lipid membranes. Med Mycol 2017;55(4):414-421.

(66) Barkan Y, Levinman M, Veprinsky-Zuzuliya I, Tsach T, Merqioul E, Blum G, et al. Comparative evaluation of polycyanoacrylates. Acta Biomater 2017;48:390-400.

(67) Kunduru KR, Basu A, Tsah T, Domb AJ. Polymer with pendant diazo-coupling functionality for colorimetric detection of nitrates. Sens Actuators, B Chem 2017;251:21-26.

(68) Ghadi R, Muntimadugu E, Domb AJ, Khan W, Zhang X. Synthetic biodegradable medical polymer: Polyanhydrides. Science and Principles of Biodegradable and Bioresorbable Medical Polymers: Materials and Properties; 2017. p. 153-188.

(69) Kunduru KR, Basu A, Abtew E, Tsach T, Domb AJ. Polymeric sensors containing P-dimethylaminocinnamaldehyde: Colorimetric detection of urea nitrate. Sens Actuators, B Chem 2017;238:387-391.

(70) Basu A, Sohn Y-, Alyan M, Nechushtai R, Domb AJ, Goldblum A. Discovering Novel and Diverse Iron-Chelators in Silico. J Chem Inf Model 2016;56(12):2476-2485.

(71) Langer R, Basu A, Domb AJ. Special issue: Polylactide (PLA) Based Biopolymers. Adv Drug Deliv Rev 2016;107:1-2.

(72) Basu A, Kunduru KR, Katzhendler J, Domb AJ. Poly(α-hydroxy acid)s and poly(α-hydroxy acid-co-α-amino acid)s derived from amino acid. Adv Drug Deliv Rev 2016;107:82-96.

(73) Ramot Y, Haim-Zada M, Domb AJ, Nyska A. Biocompatibility and safety of PLA and its copolymers. Adv Drug Deliv Rev 2016;107:153-162.

(74) Basu A, Kunduru KR, Doppalapudi S, Domb AJ, Khan W. Poly(lactic acid) based hydrogels. Adv Drug Deliv Rev 2016;107:192-205.

(75) Jain A, Kunduru KR, Basu A, Mizrahi B, Domb AJ, Khan W. Injectable formulations of poly(lactic acid) and its copolymers in clinical use. Adv Drug Deliv Rev 2016;107:213-227.

(76) Jain A, Doppalapudi S, Domb AJ, Khan W. Tacrolimus and curcumin co-loaded liposphere gel: Synergistic combination towards management of psoriasis. J Control Release 2016;243:132-145.

(77) Basu A, Haim-Zada M, Domb AJ. Biodegradable inflatable balloons for tissue separation. Biomaterials 2016;105:109-116.

(78) Katiyar SS, Muntimadugu E, Rafeeqi TA, Domb AJ, Khan W. Co-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatment. Drug Deliv 2016;23(7):2608-2616.

(79) Eckhard LH, Houri-Haddad Y, Sol A, Zeharia R, Shai Y, Beyth S, et al. Sustained release of antibacterial lipopeptides from biodegradable polymers against oral pathogens. PLoS ONE 2016;11(9).

(80) Ramot Y, Rotkopf S, Gabai RM, Zorde Khvalevsky E, Muravnik S, Marzoli GA, et al. Preclinical Safety Evaluation in Rats of a Polymeric Matrix Containing an siRNA Drug Used as a Local and Prolonged Delivery System for Pancreatic Cancer Therapy. Toxicol Pathol 2016;44(6):856-865.

(81) Abtew E, Domb AJ, Basu A. Glycopeptides derived from glucosaminic acid. Polym Chem 2016;7(27):4447-4452.

(82) Aviv O, Amir N, Laout N, Ratner S, Basu A, Domb AJ. Poly(hexamethylene guanidine)-poly(ethylene glycol) solid blend for water microbial deactivation. Polym Degradation Stab 2016;129:239-245.

(83) Haim-Zada M, Basu A, Hagigit T, Schlinger R, Grishko M, Kraminsky A, et al. Alternating Poly(ester-anhydride) by Insertion Polycondensation. Biomacromolecules 2016;17(6):2253-2259.

(84) Kunduru KR, Basu A, Domb AJ. Biodegradable fatty acid polyesters. Handbook of Polyester Drug Delivery Systems; 2016. p. 33-59.

(85) Doppalapudi S, Jain A, Domb AJ, Khan W. Biodegradable polymers for targeted delivery of anti-cancer drugs. Expert Opin Drug Deliv 2016;13(6):891-909.

(86) Ghadi R, Jain A, Khan W, Domb AJ. Microparticulate polymers and hydrogels for wound healing. Wound Healing Biomaterials; 2016. p. 203-225.

(87) Basu A, Kunduru KR, Abtew E, Domb AJ. Erratum: Polysaccharide-Based Conjugates for Biomedical Applications (Bioconjugate Chemistry (2015) 26:8 (1396-1412) DOI: 10.1021/acs.bioconjchem.5b00242). Bioconjugate Chem 2016;27(5):1427-1428.

(88) Ickowicz DE, Abtew E, Khan W, Golovanevski L, Steinman N, Weiniger CF, et al. Poly(ester-anhydride) for controlled delivery of hydrophilic drugs. J Bioact Compat Polym 2016;31(2):127-139.

(89) Farah S, Aviv O, Daif M, Reddy Kunduru K, Laout N, Ratner S, et al. N-bromo-hydantoin grafted polystyrene beads: Synthesis and nano-micro beads characteristics for achieving controlled release of active oxidative bromine and extended microbial inactivation efficiency. J Polym Sci Part A 2016;54(5):596-610.

(90) Basu A, Farah S, Kunduru KR, Doppalapudi S, Khan W, Domb AJ. Polyurethanes for Controlled Drug Delivery. Advances in Polyurethane Biomaterials; 2016. p. 217-246.

(91) Basu A, Veprinsky-Zuzulia I, Levinman M, Barkan Y, Golenser J, Domb AJ. PEG-Biscyanoacrylate Crosslinker for Octyl Cyanoacrylate Bioadhesive. Macromol Rapid Commun 2016;37(3):251-256.

(92) Ramot Y, Nyska A, Markovitz E, Dekel A, Klaiman G, Zada MH, et al. Long-term local and systemic safety of poly(l -lactide-co-epsilon-caprolactone) after subcutaneous and intra-articular implantation in rats. Toxicol Pathol 2015;43(8):1127-1140.

(93) Ortega A, Farah S, Tranque P, Ocaña AV, Nam-Cha SH, Beyth N, et al. Antimicrobial evaluation of quaternary ammonium polyethyleneimine nanoparticles against clinical isolates of pathogenic bacteria. IET Nanobiotechnol 2015;9(6):342-348.

(94) Farah S, Aviv O, Laout N, Ratner S, Domb AJ. Antimicrobial N-brominated hydantoin and uracil grafted polystyrene beads. J Control Release 2015;216:18-29.

(95) Kunduru KR, Basu A, Haim Zada M, Domb AJ. Castor Oil-Based Biodegradable Polyesters. Biomacromolecules 2015;16(9):2572-2587.

(96) Farah S, Kunduru KR, Basu A, Domb AJ. Molecular Weight Determination of Polyethylene Terephthalate. Poly(Ethylene Terephthalate) Based Blends, Composites and Nanocomposites; 2015. p. 143-165.

(97) Basu A, Kunduru KR, Abtew E, Domb AJ. Polysaccharide-Based Conjugates for Biomedical Applications. Bioconjugate Chem 2015;26(8):1396-1412.

(98) Cherniakov I, Domb AJ, Hoffman A. Self-nano-emulsifying drug delivery systems: An update of the biopharmaceutical aspects. Expert Opin Drug Deliv 2015;12(7):1121-1133.

(99) Aviv O, Farah S, Amir N, Laout N, Ratner S, Domb AJ. N-Bromo-dimethylhydantoin Polystyrene Resin for Water Microbial Decontamination. Biomacromolecules 2015;16(4):1442-1447.

(100) Farah S, Aviv O, Laout N, Ratner S, Beyth N, Domb AJ. Quaternary ammonium poly(diethylaminoethyl methacrylate) possessing antimicrobial activity. Colloids Surf B Biointerfaces 2015;128:608-613.

(101) Farah S, Aviv O, Laout N, Ratner S, Beyth N, Domb AJ. Quaternary ammonium polyethylenimine nanoparticles for treating bacterial contaminated water. Colloids Surf B Biointerfaces 2015;128:614-619.

(102) Hosseinkhani H, Abedini F, Ou K-, Domb AJ. Polymers in gene therapy technology. Polym Adv Technol 2015;26(2):198-211.

(103) Gaikwad DD, Chapolikar AD, Devkate CG, Warad KD, Tayade AP, Pawar RP, et al. Synthesis of indazole motifs and their medicinal importance: An overview. Eur J Med Chem 2015;90:707-731.

(104) Domb AJ. Letter from the editor. Polym Adv Technol 2015;26(3):213-213.

(105) Jain A, Hosseinkhani H, Domb AJ, Khan W. Cationic polymers for the delivery of therapeutic nucleotides. Polysaccharides: Bioactivity and Biotechnology; 2015. p. 1969-1990.

(106) Jain A, Muntimadugu E, Domb AJ, Khan W. Cationic polysaccharides in gene delivery. RSC Polym Chem Ser 2015;2015-January(13):228-248.

(107) Shemi A, Khvalevsky EZ, Gabai RM, Domb A, Barenholz Y. Multistep, effective drug distribution within solid tumors. Oncotarget 2015;6(37):39564-39577.

(108) Farah S, Kunduru KR, Tsach T, Bentolila A, Domb AJ. Forensic comparison of synthetic fibers. Polym Adv Technol 2015;26(7):785-796.

(109) Beyth N, Houri-Haddad Y, Domb A, Khan W, Hazan R. Alternative antimicrobial approach: Nano-antimicrobial materials. Evid -Based Complement Altern Med 2015;2015.

(110) Golovanevski L, Ickowicz D, Sokolsky-Papkov M, Domb A, Weiniger CF. In vivo study of an extended release bupivacaine formulation following site-directed nerve injection. J Bioact Compat Polym 2015;30(1):114-125.

(111) Atar-Froyman L, Sharon A, Weiss EI, Houri-Haddad Y, Kesler-Shvero D, Domb AJ, et al. Anti-biofilm properties of wound dressing incorporating nonrelease polycationic antimicrobials. Biomaterials 2015;46:141-148.

(112) Ramot Y, Touitou D, Levin G, Ickowicz DE, Zada MH, Abbas R, et al. Interspecies differences in reaction to a biodegradable subcutaneous tissue filler: Severe inflammatory granulomatous reaction in the sinclair minipig. Toxicol Pathol 2015;43(2):267-271.

(113) Golan T, Khvalevsky EZ, Hubert A, Gabai RM, Hen N, Segal A, et al. RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients. Oncotarget 2015;6(27):24560-24570.

(114) Jain A, Duvvuri LS, Farah S, Beyth N, Domb AJ, Khan W. Antimicrobial Polymers. Adv Healthc Mater 2014;3(12):1969-1985.

(115) Lendlein A, Behl M, Domb AJ. Preface. Macromol Sympos 2014;345(1):7.

(116) He W, Hosseinkhani H, Mohammadinejad R, Roveimiab Z, Hueng D-, Ou K-, et al. Polymeric nanoparticles for therapy and imaging. Polym Adv Technol 2014;25(11):1216-1225.

(117) Eckhard LH, Sol A, Abtew E, Shai Y, Domb AJ, Bachrach G, et al. Biohybrid Polymer-Antimicrobial Peptide Medium against Enterococcus faecalis. PLoS ONE 2014;9(10).

(118) Ickowicz DE, Golovanevski L, Domb AJ, Weiniger CF. Extended duration local anesthetic agent in a rat paw model. Int J Pharm 2014;468(1-2):152-157.

(119) Ickowicz DE, Farber S, Sionov E, Kagan S, Hoffman A, Polacheck I, et al. Activity, reduced toxicity, and scale-up synthesis of amphotericin B-conjugated polysaccharide. Biomacromolecules 2014;15(6):2079-2089.

(120) Lecht S, Cohen-Arazi N, Cohen G, Ettinger K, Momic T, Kolitz M, et al. Cytocompatibility of novel extracellular matrix protein analogs of biodegradable polyester polymers derived from α-hydroxy amino acids. J Biomater Sci Polym Ed 2014;25(6):608-624.

(121) Beyth N, Farah S, Domb AJ, Weiss EI. Antibacterial dental resin composites. React Funct Polym 2014;75(1):81-88.

(122) Domb AJ. Biodegradable polymers in medicine. Polym Adv Technol 2014;25(5):425-426.

(123) Lendlein A, Domb AJ, Baudis S, Behl M. From macromolecules to materials to systems. Polym Adv Technol 2014;25(11):1187-1188.

(124) Doppalapudi S, Jain A, Khan W, Domb AJ. Biodegradable polymers-an overview. Polym Adv Technol 2014;25(5):427-435.

(125) Eameema M, Duvvuri LS, Khan W, Domb AJ. Polyanhydrides. Natural and Synthetic Biomedical Polymers; 2014. p. 181-192.

(126) Farah S, Tsach T, Bentolila A, Domb AJ. Morphological, spectral and chromatography analysis and forensic comparison of PET fibers. Talanta 2014;123:54-62.

(127) Pawar RP, Tekale SU, Shisodia SU, Totre JT, Domb AJ. Biomedical applications of poly(lactic acid). Recent Pat Regen Med 2014;4(1):40-51.

(128) Ickowicz DE, Golovanevski L, Haze A, Domb AJ, Weiniger CF. Extended release local anesthetic agents in a postoperative arthritic pain model. J Pharm Sci 2014;103(1):185-190.

(129) Farah S, Aviv O, Laout N, Ratner S, Beyth N, Domb AJ. Antimicrobial silica particles loaded with quaternary ammonium polyethyleneimine network. Polym Adv Technol 2014;25(6):689-692.

(130) Yeo WWY, Hosseinkhani H, Rahman SA, Rosli R, Domb AJ, Abdullah S. Safety profile of dextran-spermine gene delivery vector in mouse lungs. J Nanosci Nanotechnol 2014;14(5):3328-3336.

(131) Sosna J, Havivi E, Khan W, Appelbaum L, Nyska A, Domb AJ. Computed tomography of Lipiodol-loaded biodegradable pasty polymer for implant visualization. Contrast Media Mol Imaging 2014;9(3):246-251.

(132) Farber S, Ickowicz DE, Melnik K, Yudovin-Farber I, Recko D, Rampersaud A, et al. Surface functionalization of magnetic nanoparticles formed by self-associating hydrophobized oxidized dextrans. J Nanopart Res 2014;16(6).

(133) Ickowicz DE, Haim-Zada M, Abbas R, Touitou D, Nyska A, Golovanevski L, et al. Castor oil-citric acid copolyester for tissue augmentation. Polym Adv Technol 2014;25(11):1323-1328.

(134) Khvalevsky EZ, Gabai R, Rachmut IH, Horwitz E, Brunschwig Z, Orbach A, et al. Mutant KRAS is a druggable target for pancreatic cancer. Proc Natl Acad Sci U S A 2013;110(51):20723-20728.

(135) Cohen-Arazi N, Domb AJ, Katzhendler J. Poly(α-hydroxy alkanoic acid)s derived from α-amino acids. Macromol Biosci 2013;13(12):1689-1699.

(136) Muntimadugu E, Ickowicz DE, Domb AJ, Khan W. Polysaccharide biomaterials. Isr J Chem 2013;53(9-10):787-794.

(137) Elgart A, Cherniakov I, Aldouby Y, Domb AJ, Hoffman A. Improved oral bioavailability of BCS class 2 compounds by self nano-emulsifying drug delivery systems (SNEDDS): The underlying mechanisms for amiodarone and talinolol. Pharm Res 2013;30(12):3029-3044.

(138) Aviv O, Laout N, Ratner S, Harik O, Kunduru KR, Domb AJ. Controlled iodine release from polyurethane sponges for water decontamination. J Control Release 2013;172(3):634-640.

(139) Kuklev DV, Domb AJ, Dembitsky VM. Bioactive acetylenic metabolites. Phytomedicine 2013;20(13):1145-1159.

(140) Saravanan M, Domb AJ. A contemporary review on - Polymer stereocomplexes and its biomedical application. Eur J Nanomed 2013;5(2):81-96.

(141) Han J, Farah S, Domb AJ, Lelkes PI. Electrospun Rapamycin-Eluting Polyurethane Fibers for Vascular Grafts. Pharm Res 2013;30(7):1735-1748.

(142) Hosseinkhani H, He W-, Chiang C-, Hong P-, Yu D-, Domb AJ, et al. Biodegradable nanoparticles for gene therapy technology. J Nanopart Res 2013;15(7).

(143) Bentolila A, Totre J, Zozulia I, Levin-Elad M, Domb AJ. Fluorescent cyanoacrylate monomers and polymers for fingermark development. Macromolecules 2013;46(12):4822-4828.

(144) Amini R, Jalilian FA, Abdullah S, Veerakumarasivam A, Hosseinkhani H, Abdulamir AS, et al. Dynamics of PEGylated-dextran-spermine nanoparticles for gene delivery to leukemic cells. Appl Biochem Biotechnol 2013;170(4):841-853.

(145) Khan W, Farah S, Nyska A, Domb AJ. Carrier free rapamycin loaded drug eluting stent: In vitro and in vivo evaluation. J Control Release 2013;168(1):70-76.

(146) Vaisman B, Ickowicz DE, Abtew E, Haim-Zada M, Shikanov A, Domb AJ. In vivo degradation and elimination of injectable ricinoleic acid-based poly(ester-anhydride). Biomacromolecules 2013;14(5):1465-1473.

(147) Wiesner S, Izraeli E, Shor Y, Domb A. Lifting Bloody Footwear Impressions Using Alginate Casts Followed by Chemical Enhancement. J Forensic Sci 2013;58(3):782-788.

(148) Farah S, Khan W, Farber I, Kesler-Shvero D, Beyth N, Weiss EI, et al. Crosslinked QA-PEI nanoparticles: Synthesis reproducibility, chemical modifications, and stability study. Polym Adv Technol 2013;24(5):446-452.

(149) Khan W, Muthupandian S, Domb AJ. Cationic polymers for the delivery of therapeutic nucleotides. Nanotechnology for the Delivery of Therapeutic Nucleic Acids; 2013. p. 27-56.

(150) Farah S, Khan W, Domb AJ. Crystalline coating of rapamycin onto a stent: Process development and characterization. Int J Pharm 2013;445(1-2):20-28.

(151) Domb AJ, Khan W. Biodegradable polymers as drug carrier systems. Polymeric Biomaterials: Structure and Function; 2013. p. 135-165.

(152) Levinson J, Domb A. Disaster victim identification In Israel: A multi-disciplinary approach. Anil Aggrawal's Internet J Forensic Med Toxicol 2013;14(2).

(153) Quaternary ammonium antimicrobial polymers. Materials Research Society Symposium Proceedings; 2013.

(154) Ameta KL, Pawar RP, Domb AJ. Preface. Bioactive Heterocycles: Synth and Biol Evaluation 2013.

(155) Ameta KL, Pawar RP, Domb AJ. Bioactive heterocycles: Synthesis and biological evaluation. Bioactive Heterocycles: Synthesis and Biological Evaluation; 2013. p. 1-305.

(156) Thipparaboina R, Khan W, Domb AJ. Eluting combination drugs from stents. Int J Pharm 2013;454(1):4-10.

(157) Hiremath JG, Rajeshkumar A, Ickowicz D, Domb AJ. Preparation and in vitro characterization of paclitaxel containing poly(lactic acid co-castor oil)-based nanodispersions. J Drug Deliv Sci Technol 2013;23(5):439-444.

(158) Hosseinkhani H, Chen Y-, He W, Hong P-, Yu D-, Domb AJ. Engineering of magnetic DNA nanoparticles for tumor-targeted therapy. J Nanopart Res 2013;15(1).

(159) Sarda SR, Mirgane SR, Jadhav WN, Wasmatkar SK, Deshmukh SU, Ubale SB, et al. Synthesis and biological evaluation of flavones. Bioactive Heterocycles: Synthesis and Biological Evaluation; 2013. p. 235-258.

(160) Hosseinkhani H, Hong P-, Yu D-, Chen Y-, Ickowicz D, Farber I-, et al. Development of 3D in vitro platform technology to engineer mesenchymal stem cells. Int J Nanomed 2012;7:3035-3043.

(161) Abedini F, Hosseinkhani H, Ismail M, Domb AJ, Omar AR, Chong PP, et al. Cationized dextran nanoparticle-encapsulated CXCR4-siRNA enhanced correlation between CXCR4 expression and serum alkaline phosphatase in a mouse model of colorectal cancer. Int J Nanomed 2012;7:4159-4168.

(162) Beyth N, Yudovin-Farber I, Weiss EI, Domb AJ. Antimicrobial Nanoparticles in Restorative Composites. Emerging Nanotechnologies in Dentistry; 2012. p. 35-47.

(163) Khan W, Hosseinkhani H, Ickowicz D, Hong P-, Yu D-, Domb AJ. Polysaccharide gene transfection agents. Acta Biomater 2012;8(12):4224-4232.

(164) Gref R, Domb A, Quellec P, Blunk T, Müller RH, Verbavatz JM, et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev 2012;64(SUPPL.):316-326.

(165) Khan W, Aldouby YH, Avramoff A, Domb AJ. Cyclosporin nanosphere formulation for ophthalmic administration. Int J Pharm 2012;437(1-2):275-276.

(166) Kagan S, Ickowicz D, Shmuel M, Altschuler Y, Sionov E, Pitusi M, et al. Toxicity mechanisms of amphotericin B and its neutralization by conjugation with arabinogalactan. Antimicrob Agents Chemother 2012;56(11):5603-5611.

(167) Avramoff A, Khan W, Mizrahi B, Domb AJ. Preparation and characterization of a novel once-daily formulation of diltiazem using arabinogalactan as a channeling agent. J Appl Polym Sci 2012;126(SUPPL. 1):E197-E203.

(168) Levy-Nissenbaum E, Khan W, Pawar RP, Tabakman R, Naftali E, Winkler I, et al. Pharmacokinetic and efficacy study of cisplatin and paclitaxel formulated in a new injectable poly(sebacic-co-ricinoleic acid) polymer. Eur J Pharm Biopharm 2012;82(1):85-93.

(169) Weiniger CF, Golovanevski L, Domb AJ, Ickowicz D. Extended release formulations for local anaesthetic agents. Anaesthesia 2012;67(8):906-916.

(170) Khan W, Farah S, Domb AJ. Drug eluting stents: Developments and current status. J Control Release 2012;161(2):703-712.

(171) Hiremath JG, Rudani CG, Domb AJ, Suthar RV, Khamar NS. Preparation and in vitro characterization of poly(sebacic acid-co-ricinoleic acid)-based tamoxifen citrate-loaded microparticles for breast cancer. J Appl Polym Sci 2012;124(6):4747-4754.

(172) Avramoff A, Khan W, Ezra A, Elgart A, Hoffman A, Domb AJ. Cyclosporin pro-dispersion liposphere formulation. J Control Release 2012;160(2):401-406.

(173) Elgart A, Cherniakov I, Aldouby Y, Domb AJ, Hoffman A. Lipospheres and pro-nano lipospheres for delivery of poorly water soluble compounds. Chem Phys Lipids 2012;165(4):438-453.

(174) Levy Y, Khan W, Farah S, Domb AJ. Surface crystallization of rapamycin on stents using a temperature induced process. Langmuir 2012;28(15):6207-6210.

(175) Sokolsky-Papkov M, Golovanevski L, Domb AJ, Weiniger CF. Erratum: Sokolsky-Papkov M, Golovanevski L, Domb A, Weiniger C. 2010. Poly(d,l:lactic-acid-castor oil) 3:7-bupivacaine formulation: Reducing burst effect prolongs efficacy in vivo. J Pharm Sci 99:2732-2738. J Pharm Sci 2012;101(2):884.

(176) Khan W, Muthupandian S, Farah S, Kumar N, Domb AJ. Biodegradable polymers derived from amino acids. Macromol Biosci 2011;11(12):1625-1636.

(177) Sokolsky-Papkov M, Golovanevski L, Domb AJ, Weiniger CF. Long-acting poly(DL:lactic acid-castor oil) 3:7-bupivacaine formulation: Effect of hydrophobic additives. Pharm Res 2011;28(12):3265-3273.

(178) Abedini F, Ismail M, Hosseinkhani H, Ibrahim TAT, Omar AR, Chong PP, et al. Effects of CXCR4 siRNA/dextran-spermine nanoparticles on CXCR4 expression and serum LDH levels in a mouse model of colorectal cancer metastasis to the liver. Cancer Manage Res 2011;3(1):301-309.

(179) Domb A, Jain JP, Kumar N. Polyanhydrides. Handbook of Biodegradable Polymers: Isolation, Synthesis, Characterization and Applications; 2011. p. 45-75.

(180) Domb AJ, Kumar N, Ezra A. Biodegradable Polymers in Clinical Use and Clinical Development. Biodegradable Polymers in Clinical Use and Clinical Development; 2011.

(181) Totre J, Ickowicz D, Domb AJ. Properties and Hemostatic Application of Gelatin. Biodegradable Polymers in Clinical Use and Clinical Development; 2011. p. 91-109.

(182) Khan W, Yadav D, Domb AJ, Kumar N. Collagen. Biodegradable Polymers in Clinical Use and Clinical Development; 2011. p. 59-89.

(183) Jain JP, Yenet Ayen W, Domb AJ, Kumar N. Biodegradable Polymers in Drug Delivery. Biodegradable Polymers in Clinical Use and Clinical Development; 2011. p. 1-58.

(184) Borade RM, Domb AJ, Sawale AA, Pawar RP, Kharat KR. Polyanhydrides-Poly(CPP-SA), Fatty-Acid-Based Polyanhydrides. Biodegradable Polymers in Clinical Use and Clinical Development; 2011. p. 367-400.

(185) Pawar RP, Jadhav AE, Tathe SB, Khade BC, Domb AJ. Medicinal Applications of Cyanoacrylate. Biodegradable Polymers in Clinical Use and Clinical Development; 2011. p. 417-449.

(186) Pawar RP, Kushekar BA, Jadhav BS, Kharat KR, Borade RM, Domb AJ. Arabinogalactan in Clinical Use. Biodegradable Polymers in Clinical Use and Clinical Development; 2011. p. 217-245.

(187) Sokolsky-Papkov M, Langer R, Domb AJ. Synthesis of aliphatic polyesters by polycondensation using inorganic acid as catalyst. Polym Adv Technol 2011;22(5):502-511.

(188) Domb AJ. Tenth PAT symposium, Jerusalem, 2009: In honor of Professor Menachem Lewin's 90th birthday. Polym Adv Technol 2011;22(1):1-2.

(189) Yudovin-Farber I, Eliyahu H, Domb AJ. Synthesis of cationic polysaccharides and use for in vitro transfection. Cold Spring Harbor Protoc 2011;6(1).

(190) Havivi E, Farber S, Domb AJ. Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for delivery of tamsulosin hydrochloride. Polym Adv Technol 2011;22(1):114-118.

(191) Verma S, Domb AJ, Kumar N. Nanomaterials for regenerative medicine. Nanomedicine 2011;6(1):157-181.

(192) Hiremath JG, Rudani CG, Suthar RV, Domb AJ. Tamoxifen citrate loaded biodegradable poly(sebacic acid-co-ricinoleic acid) microparticles, in vitro characterization. J Drug Deliv Sci Technol 2011;21(5):417-422.

(193) Hosseinkhani H, Hosseinkhani M, Chen Y-, Subramani K, Domb AJ. Innovative technology of engineering magnetic DNA nanoparticles for gene therapy. Int J Nanotechnol 2011;8(8-9):724-735.

(194) Farber S, Ickowicz D, Sionov E, Kagan S, Polacheck I, Domb AJ. Galactomannan-amphotericin B conjugate: Synthesis and biological activity. Polym Adv Technol 2011;22(1):119-125.

(195) Abedini F, Hosseinkhani H, Ismail M, Chen Y-, Omar AR, Chong PP, et al. In vitro intracellular trafficking of biodegradable nanoparticles dextran-spermine in cancer cell lines. Int J Nanotechnol 2011;8(8-9):712-723.

(196) Beyth N, Yudovin-Farber I, Perez-Davidi M, Domb AJ, Weiss EI. Polyethyleneimine nanoparticles incorporated into resin composite cause cell death and trigger biofilm stress in vivo. Proc Natl Acad Sci U S A 2010;107(51):22038-22043.

(197) Okner R, Favaro G, Radko A, Domb AJ, Mandler D. Electrochemical codeposition of sol-gel films on stainless steel: Controlling the chemical and physical coating properties of biomedical implants. Phys Chem Chem Phys 2010;12(46):15265-15273.

(198) Cohen-Arazi N, Domb AJ, Katzhendler J. New biocompatible polyesters derived from α-amino acids: Hydrolytic degradation behavior. Polym 2010;2(4):418-439.

(199) Abdullah S, Wendy-Yeo WY, Hosseinkhani H, Hosseinkhani M, Masrawa E, Ramasamy R, et al. Gene transfer into the lung by nanoparticle dextran-spermine/plasmid DNA complexes. J Biomed Biotechnol 2010;2010.

(200) Domb AJ, Yudovin-Farber I, Golenser J, Beyth N, Weiss EI. Quaternary ammonium polyethyleneimine: Antibacterial activity. J Nanomater 2010;2010.

(201) Elgart A, Farber S, Domb AJ, Polacheck I, Hoffman A. Polysaccharide pharmacokinetics: Amphotericin B arabinogalactan conjugate-A drug delivery system or a new pharmaceutical entity? Biomacromolecules 2010;11(8):1972-1977.

(202) Łukaszczyk J, Jelonek P, Trzebicka B, Domb AJ. Stereocomplexes formation from enantiomeric star-shaped block copolymers of ε-caprolactone and lactide. E-Polymers 2010.

(203) Pawar RP, Kharat KR, Domb AJ. Pasty polymers in cancer drug therapy. Isr J Chem 2010;50(2):233-238.

(204) Zhang J, Li C, Duan Y, Domb AJ, Ozaki Y. Glass transition and disorder-to-order phase transition behavior of poly(l-lactic acid) revealed by infrared spectroscopy. Vib Spectrosc 2010;53(2):307-310.

(205) Weiniger CF, Golovanevski M, Sokolsky-Papkov M, Domb AJ. Review of prolonged local anesthetic action. Expert Opin Drug Deliv 2010;7(6):737-752.

(206) Zhang J, Duan Y, Domb AJ, Ozaki Y. PLLA mesophase and its phase transition behavior in the PLLA-PEG-PLLA copolymer as revealed by infrared spectroscopy. Macromolecules 2010;43(9):4240-4246.

(207) Eljarrat-Binstock E, Pe'er J, Domb AJ. New techniques for drug delivery to the posterior eye segment. Pharm Res 2010;27(4):530-543.

(208) Shikanov A, Vaisman B, Shikanov S, Domb AJ. Efficacy of poly(sebacic acid-co-ricinoleic acid) biodegradable delivery system for intratumoral delivery of paclitaxel. J Biomed Mater Res Part A 2010;92(4):1283-1291.

(209) Vaisman B, Motiei M, Nyska A, Domb AJ. Biocompatibility and safety evaluation of a ricinoleic acid-based poly(ester-anhydride) copolymer after implantation in rats. J Biomed Mater Res Part A 2010;92(2):419-431.

(210) Pinhassi RI, Assaraf YG, Farber S, Stark M, Ickowicz D, Drori S, et al. Arabinogalactan-folic acid-drug conjugate for targeted delivery and target-activated release of anticancer drugs to folate receptor-overexpressing cells. Biomacromolecules 2010;11(1):294-303.

(211) Avramoff A, Domb AJ. In-vitro and in-vivo characteristics of a modified-release double-pulse formulation for a water soluble drug. Int J Clin Pharmacol Ther 2010;48(4):250-258.

(212) Beyth N, Yudovin-Fearber I, Domb AJ, Weiss EI. Long-term antibacterial surface properties of composite resin incorporating polyethyleneimine nanoparticles. Quintessence Int 2010;41(10):827-835.

(213) Yudovin-Farber I, Beyth N, Weiss EI, Domb AJ. Antibacterial effect of composite resins containing quaternary ammonium polyethyleneimine nanoparticles. J Nanopart Res 2010;12(2):591-603.

(214) Aframian DJ, Mizrahi B, Granot I, Domb AJ. Evaluation of a mucoadhesive lipid-based bioerodable tablet compared with Biotène mouthwash for dry mouth relief-A pilot study. Quintessence Int 2010;41(3):e36-e42.

(215) Sokolsky-Papkov M, Golovanevski L, Domb AJ, Weiniger CF. Poly(DL:lactic acid-castor oil) 3:7-bupivacaine formulation: Reducing burst effect prolongs efficacy in vivo. J Pharm Sci 2010;99(6):2732-2738.

(216) Pawar RP, Shinde NR, Andurkar NM, Dake SA, Domb AJ. Injectable polymers for regional drug delivery. Targeted Delivery of Small and Macromolecular Drugs; 2010. p. 457-480.

(217) Srichana T, Domb AJ. Polymeric biomaterials. Biomedical Materials; 2009. p. 83-119.

(218) Veronesi MC, Aldouby Y, Domb AJ, Kubek MJ. Thyrotropin-releasing hormone d,l polylactide nanoparticles (TRH-NPs) protect against glutamate toxicity in vitro and kindling development in vivo. Brain Res 2009;1303:151-160.

(219) Shaulov Y, Okner R, Levi Y, Tal N, Gutkin V, Mandler D, et al. Poly(methyl methacrylate) grafting onto stainless steel surfaces: Application to drug-eluting stents. ACS Appl Mater Interfaces 2009;1(11):2519-2528.

(220) Yudovin-Farber I, Gurt I, Hope R, Domb AJ, Katz E. Inhibition of herpes simplex virus by polyamines. Antiviral Chem Chemother 2009;20(2):87-98.

(221) Levy Y, Tal N, Tzemach G, Weinberger J, Domb AJ, Mandler D. Drug-eluting stent with improved durability and controllability properties, obtained via electrocoated adhesive promotion layer. J Biomed Mater Res Part B Appl Biomater 2009;91(2):819-830.

(222) Levy Y, Paz A, Yosef RB, Corn BW, Vaisman B, Shuhat S, et al. Biodegradable inflatable balloon for reducing radiation adverse effects in prostate cancer. J Biomed Mater Res Part B Appl Biomater 2009;91(2):855-867.

(223) Farber S, Green BS, Domb AJ. Selective 17-β-estradiol molecular imprinting. J Polym Sci Part A 2009;47(20):5534-5542.

(224) Levy Y, Mandler D, Weinberger J, Domb AJ. Evaluation of drug-eluting stents' coating durability - Clinical and regulatory implications. J Biomed Mater Res Part B Appl Biomater 2009;91(1):441-451.

(225) Slager J, Tyler B, Shikanov A, Domb AJ, Shogen K, Sidransky D, et al. Local controlled delivery of anti-neoplastic RNAse to the brain. Pharm Res 2009;26(8):1838-1846.

(226) Kolitz M, Cohen-Arazi N, Hagag H, Katzhendler J, Domb AJ. Biodegradable polyesters derived from amino acids. Macromolecules 2009;42(13):4520-4530.

(227) Okner R, Shaulov Y, Tal N, Favaro G, Domb AJ, Mandler D. Electropolymerized tricopolymer based on N-pyrrole derivatives as a primer coating for improving the performance of a drug-eluting stent. ACS Appl Mater Interfaces 2009;1(4):758-767.

(228) Mizrahi B, Domb AJ. Anhydride prodrug of ibuprofen and acrylic polymers. AAPS PharmSciTech 2009;10(2):453-458.

(229) Kubek MJ, Domb AJ, Veronesi MC. Attenuation of Kindled Seizures by Intranasal Delivery of Neuropeptide-Loaded Nanoparticles. Neurotherapeutics 2009;6(2):359-371.

(230) Brin YS, Nyska A, Domb AJ, Golenser J, Mizrahi B, Nyska M. Biocompatibility of a polymeric implant for the treatment of osteomyelitis. J Biomater Sci Polym Ed 2009;20(7-8):1081-1090.

(231) Ben-Yosef R, Paz A, Levy Y, Alani S, Muncher Y, Shohat S, et al. A Novel Device for Protecting Rectum During Prostate Cancer Irradiation: In Vivo Data on a Large Mammal Model. J Urol 2009;181(3):1401-1406.

(232) Okner R, Oron M, Tal N, Nyska A, Kumar N, Mandler D, et al. Electrocoating of stainless steel coronary stents for extended release of paclitaxel. J Biomed Mater Res Part A 2009;88(2):427-436.

(233) Okner R, Domb AJ, Mandler D. Electrochemically deposited poly(ethylene glycol)-based sol-gel thin films on stainless steel stents. New J Chem 2009;33(7):1596-1604.

(234) Sokolsky-Papkov M, Golovanevski L, Domb AJ, Weiniger CF. Prolonged local anesthetic action through slow release from poly(lactic acid co castor oil). Pharm Res 2009;26(1):32-39.

(235) Sokolsky-Papkov M, Shikanov A, Ezra A, Vaisman B, Domb AJ. Fatty acid-based biodegradable polymers: Synthesis and applications. ACS Symp Ser 2009;1004:60-69.

(236) Shikanov S, Shikanov A, Gofrit O, Nyska A, Corn B, Domb AJ. Intratumoral delivery of paclitaxel for treatment of orthotopic prostate cancer. J Pharm Sci 2009;98(3):1005-1014.

(237) Eljarrat-Binstock E, Domb AJ, Orucov F, Dagan A, Frucht-Pery J, Pe'Er J. In vitro and in vivo evaluation of carboplatin delivery to the eye using hydrogel-iontophoresis. Curr Eye Res 2008;33(3):269-275.

(238) Yudovin-Farber I, Beyth N, Nyska A, Weiss EI, Golenser J, Domb AJ. Surface characterization and biocompatibility of restorative resin containing nanoparticles. Biomacromolecules 2008;9(11):3044-3050.

(239) Beyth N, Houri-Haddad Y, Baraness-Hadar L, Yudovin-Farber I, Domb AJ, Weiss EI. Surface antimicrobial activity and biocompatibility of incorporated polyethylenimine nanoparticles. Biomaterials 2008;29(31):4157-4163.

(240) Cohen-Arazi N, Katzhendler J, Kolitz M, Domb AJ. Preparation of new α-hydroxy acids derived from amino acids and their corresponding polyesters. Macromolecules 2008;41(20):7259-7263.

(241) Brin YS, Golenser J, Mizrahi B, Maoz G, Domb AJ, Peddada S, et al. Treatment of osteomyelitis in rats by injection of degradable polymer releasing gentamicin. J Control Release 2008;131(2):121-127.

(242) Perez Davidi M, Hadad A, Weiss EI, Domb A, Mizrahi B, Sterer N. The effect of a mild increase in temperature on tooth bleaching. Quintessence Int 2008;39(9):771-775.

(243) Mizrahi B, Shavit R, Domb AJ. Synthesis and characterization of polymeric implant for kyphoplasty. J Biomed Mater Res Part B Appl Biomater 2008;86(2):466-473.

(244) Sterer N, Nuas S, Mizrahi B, Goldenberg C, Weiss EI, Domb A, et al. Oral malodor reduction by a palatal mucoadhesive tablet containing herbal formulation. J Dent 2008;36(7):535-539.

(245) Shikanov A, Shikanov S, Vaisman B, Golenser J, Domb AJ. Paclitaxel tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant. Int J Pharm 2008;358(1-2):114-120.

(246) Mizrahi B, Domb AJ. Mucoadhesive polymers for delivery of drugs to the oral cavity. Recent Pat Drug Deliv Formulation 2008;2(2):108-119.

(247) Sokolsky-Papkov M, Domb AJ. Stereoisomeric effect on in vitro drug release from injectable poly(lactic acid co castor oil) polyesters. Polym Adv Technol 2008;19(6):671-679.

(248) Eljarrat-Binstock E, Orucov F, Frucht-Pery J, Pe'er J, Domb AJ. Methylprednisolone delivery to the back of the eye using hydrogel iontophoresis. J Ocul Pharmacol Ther 2008;24(3):344-350.

(249) Beyth N, Bahir R, Matalon S, Domb AJ, Weiss EI. Streptococcus mutans biofilm changes surface-topography of resin composites. Dent Mater 2008;24(6):732-736.

(250) Hiremath JG, Kusum Devi V, Devi K, Domb AJ. Biodegradable poly(sebacic acid-co-ricinoleic-ester anhydride) tamoxifen citrate implants: Preparation and in vitro characterization. J Appl Polym Sci 2008;107(5):2745-2754.

(251) Eljarrat-Binstock E, Orucov F, Aldouby Y, Frucht-Pery J, Domb AJ. Charged nanoparticles delivery to the eye using hydrogel iontophoresis. J Control Release 2008;126(2):156-161.

(252) Zhang J, Tashiro K, Tsuji H, Domb AJ. Disorder-to-order phase transition and multiple melting behavior of poly(L-lactide) investigated by simultaneous measurements of WAXD and DSC. Macromolecules 2008;41(4):1352-1357.

(253) Vaisman B, Shikanov A, Domb AJ. The isolation of ricinoleic acid from castor oil by salt-solubility-based fractionation for the biopharmaceutical applications. JAOCS J Am Oil Chem Soc 2008;85(2):169-184.

(254) Jain JP, Sokolsky M, Kumar N, Domb AJ. Fatty acid based biodegradable polymer. Pol Rev 2008;48(1):156-191.

(255) Berger R, Avramoff A, Leiba M, Domb AJ, Laor A, Nagler A. Cyclosporine safety and bioavailability with two second-generation softgel capsules using serum concentrations/TDM and modeling in transplant patients - A retrospective, parallel, comparative evaluation study. Int J Clin Pharmacol Ther 2008;46(4):165-171.

(256) Shemer A, Amichai B, Trau H, Nathansohn N, Mizrahi B, Domb AJ. Efficacy of a mucoadhesive patch compared with an oral solution for treatment of aphthous stomatitis. Drugs R D 2008;9(1):29-35.

(257) Pawar R, Jadhav W, Bhusare S, Borade R, Farber S, Itzkowitz D, et al. Polysaccharides as carriers of bioactive agents for medical applications. Natural-Based Polymers for Biomedical Applications; 2008. p. 3-53.

(258) Krasko MY, Domb AJ. Pasty injectable biodegradable polymers derived from natural acids. J Biomed Mater Res Part A 2007;83(4):1138-1145.

(259) Fay F, Linossier I, Langlois V, Vallee-Rehel K, Krasko MY, Domb AJ. Protecting biodegradable coatings releasing antimicrobial agents. J Appl Polym Sci 2007;106(6):3768-3777.

(260) Marom G, Domb AJ. In memory of Professor Yair Avny (1937-2006). Polym Adv Technol 2007;18(9):679-680.

(261) Okner R, Domb AJ, Mandler D. Electrochemical formation and characterization of copolymers based on N-pyrrole derivatives. Biomacromolecules 2007;8(9):2928-2935.

(262) Eljarrat-Binstock E, Bentolila A, Kumar N, Harel H, Domb AJ. Preparation, characterization, and sterilization of hydrogel sponges for iontophoretic drug-delivery use. Polym Adv Technol 2007;18(9):720-730.

(263) Shustak G, Shaulov Y, Domb AJ, Mandler D. Electrostatic attachment of gold and poly(lactic acid) nanoparticles onto ω-aminoalkanoic acid self-assembled monolayers on 316l stainless steel. Chem Eur J 2007;13(22):6402-6407.

(264) Zhang J, Beshra A, Domb AJ, Ozaki Y. d-Poly(lactide) and LHRH decapeptide stereointeractions investigated by vibrational spectroscopy. Eur Polym J 2007;43(7):3016-3027.

(265) Eljarrat-Binstock E, Domb AJ, Orucov F, Frucht-Pery J, Pe'er J. Methotrexate delivery to the eye using transscleral hydrogel iontophoresis. Curr Eye Res 2007;32(7-8):639-646.

(266) Domb A, Mikos AG. Matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007;59(4-5):185-186.

(267) Sokolsky-Papkov M, Agashi K, Olaye A, Shakesheff K, Domb AJ. Polymer carriers for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007;59(4-5):187-206.

(268) Eliyahu H, Joseph A, Schillemans JP, Azzam T, Domb AJ, Barenholz Y. Characterization and in vivo performance of dextran-spermine polyplexes and DOTAP/cholesterol lipoplexes administered locally and systemically. Biomaterials 2007;28(14):2339-2349.

(269) Yudovin-Farber I, Domb AJ. Cationic polysaccharides for gene delivery. Mater Sci Eng C 2007;27(3):595-598.

(270) Okner R, Oron M, Tal N, Mandler D, Domb AJ. Electrocoating of stainless steel coronary stents for extended release of Paclitaxel. Mater Sci Eng C 2007;27(3):510-513.

(271) Beyth N, Domb AJ, Weiss EI. An in vitro quantitative antibacterial analysis of amalgam and composite resins. J Dent 2007;35(3):201-206.

(272) Schumacher I, Tsiperman E, Tarnopolsky A, Raskin A, Sigler E, Domb AJ. Quality and stability evaluation of disposable medical equipment. Polym Adv Technol 2007;18(3):207-212.

(273) Zhang J, Tashiro K, Tsuji H, Domb AJ. Investigation of phase transitional behavior of poly(L-lactide)/ poly(D-lactide) blend used to prepare the highly-oriented stereocomplex. Macromolecules 2007;40(4):1049-1054.

(274) Shikanov A, Domb AJ, Weiniger CF. Long acting local anesthetic-polymer formulation to prolong the effect of analgesia. J Control Release 2007;117(1):97-103.

(275) Krasko MY, Golenser J, Nyska A, Nyska M, Brin YS, Domb AJ. Gentamicin extended release from an injectable polymeric implant. J Control Release 2007;117(1):90-96.

(276) Mizrahi B, Domb AJ. Mucoadhesive tablet releasing iodine for treating oral infections. J Pharm Sci 2007;96(11):3144-3150.

(277) Raiskup-Wolf F, Eljarrat-Binstock E, Rehák M, Domb A, Frucht-Pery J. Transcorneal and transscleral iontophoresis of the dexamethasone phosphate into the rabbit eye. Ceska Slov Oftalmol 2007;63(5):360-368.

(278) Avramoff A, Laor A, Kitzes-Cohen R, Farin D, Domb AJ. Comparative in vivo bioequivalence and in vitro dissolution of two cyclosporin A soft gelatin capsule formulations. Int J Clin Pharmacol Ther 2007;45(2):126-132.

(279) Shustak G, Gadzinowski M, Slomkowski S, Domb AJ, Mandler D. A novel electrochemically synthesized biodegradable thin film of polypyrrole-polyethyleneglycol-polylactic acid nanoparticles. New J Chem 2007;31(1):163-168.

(280) Zhang J, Tashiro K, Domb AJ, Tsuji H. Confirmation of disorder α form of poly(L-lactic acid) by the X-ray fiber pattern and polarized IR/Raman spectra measured for uniaxially-oriented samples. Macromol Sympos 2006;242:274-278.

(281) Ben-Shabat S, Kumar N, Domb AJ. PEG-PLA block copolymer as potential drug carrier: Preparation and characterization. Macromol Biosci 2006;6(12):1019-1025.

(282) Chitkara D, Shikanov A, Kumar N, Domb AJ. Biodegradable injectable in situ depot-forming drug delivery systems. Macromol Biosci 2006;6(12):977-990.

(283) Modi S, Jain JP, Domb AJ, Kumar N. Exploiting EPR in polymer drug conjugate delivery for tumor targeting. Curr Pharm Des 2006;12(36):4785-4796.

(284) Frucht-Pery J, Raiskup F, Mechoulam H, Shapiro M, Eljarrat-Binstock E, Domb A. Iontophoretic treatment of experimental pseudomonas keratitis in rabbit eyes using gentamicin-loaded hydrogels. Cornea 2006;25(10):1182-1186.

(285) Modi S, Jain JP, Domb AJ, Kumar N. Copolymers of pharmaceutical grade lactic acid and sebacic acid: Drug release behavior and biocompatibility. Eur J Pharm Biopharm 2006;64(3):277-286.

(286) Gafni Y, Zilberman Y, Ophir Z, Abramovitch R, Jaffe M, Gazit Z, et al. Design of a filamentous polymeric scaffold for in vivo guided angiogenesis. Tissue Eng 2006;12(11):3021-3034.

(287) Ben-Shabat S, Domb AJ. Synthesis of pendent carbonate ester groups onto aliphatic polycarbonates. J Bioact Compat Polym 2006;21(5):385-397.

(288) Krasko MY, Kumar N, Domb AJ. Protein and peptide release from in situ gelling polymer. Biomacromolecules 2006;7(8):2461-2463.

(289) Chorny M, Mishaly D, Leibowitz A, Domb AJ, Golomb G. Site-specific delivery of dexamethasone from biodegradable implants reduces formation of pericardial adhesions in rabbits. J Biomed Mater Res Part A 2006;78(2):276-282.

(290) Hosseinkhani H, Azzam T, Kobayashi H, Hiraoka Y, Shimokawa H, Domb AJ, et al. Combination of 3D tissue engineered scaffold and non-viral gene carrier enhance in vitro DNA expression of mesenchymal stem cells. Biomaterials 2006;27(23):4269-4278.

(291) Beyth N, Yudovin-Farber I, Bahir R, Domb AJ, Weiss EI. Antibacterial activity of dental composites containing quaternary ammonium polyethylenimine nanoparticles against Streptococcus mutans. Biomaterials 2006;27(21):3995-4002.

(292) Shustak G, Domb AJ, Mandler D. n-Alkanoic acid monolayers on 316L stainless steel promote the adhesion of electropolymerized polypyrrole films. Langmuir 2006;22(12):5237-5240.

(293) Slivniak R, Ezra A, Domb AJ. Hydrolytic degradation and drug release of ricinoleic acid-lactic acid copolyesters. Pharm Res 2006;23(6):1306-1312.

(294) Mizrahi B, Shapira L, Domb AJ, Houri-Haddad Y. Citrus oil and MgCl2 as antibacterial and anti-inflammatory agents. J Periodontol 2006;77(6):963-968.

(295) Sokolsky-Papkov M, Domb AJ, Golenser J. Impact of aldehyde content on amphotericin B - Dextran imine conjugate toxicity. Biomacromolecules 2006;7(5):1529-1535.

(296) Eliyahu H, Joseph A, Azzam T, Barenholz Y, Domb AJ. Dextran-spermine-based polyplexes - Evaluation of transgene expression and of local and systemic toxicity in mice. Biomaterials 2006;27(8):1636-1645.

(297) Eliyahu H, Siani S, Azzam T, Domb AJ, Barenholz Y. Relationships between chemical composition, physical properties and transfection efficiency of polysaccharide-spermine conjugates. Biomaterials 2006;27(8):1646-1655.

(298) Eljarrat-Binstock E, Domb AJ. Iontophoresis: A non-invasive ocular drug delivery. J Control Release 2006;110(3):479-489.

(299) Golenser J, Domb A. New formulations and derivatives of Amphotericin B for treatment of leishmaniasis. Mini-Rev Med Chem 2006;6(2):153-162.

(300) Golenser J, Domb A, Mordechal-Daniel T, Leshem B, Lutyt A, Kremsner P. Iron chelators: Correlation between effects on Plasmodium spp. and immune functions. J Parasitol 2006;92(1):170-177.

(1) Kumar S, Kolodkin-Gal I, Vesper O, Alam N, Schueler-Furman O, Moll I, et al. Correction for kumar et al., “Escherichia coli quorum-sensing EDF, a peptide generated by novel multiple distinct mechanisms and regulated by trans-translation”. mBio 2021;12(1):1.

(2) Erental A, Kalderon Z, Saada A, Smith Y, Engelberg-Kulka H. Erratum: Correction for Erental et al., "Apoptosis-Like Death, an Extreme SOS Response in Escherichia coli" (mBio (2014) 5 4 (e01426-e01414) PII: e03040-20). mBio 2020;11(6).

(3) Nigam A, Oron-Gottesman A, Engelberg-Kulka H. A bias in the reading of the genetic code of escherichia coli is a characteristic for genes that specify stress-induced mazf-mediated proteins. Curr Genomics 2020;21(4):311-318.

(4) Nigam A, Ziv T, Oron-Gottesman A, Engelberg-Kulka H. Reply to Kaldalu et al., “Reanalysis of proteomics results fails to detect MazF-mediated stress proteins”. mBio 2019;10(3).

(5) Nigam A, Ziv T, Oron-Gottesman A, Engelberg-Kulka H. Reply to wade and laub, ‘concerns about “stress-induced mazf-mediated proteins in escherichia coli”’. mBio 2019;10(3).

(6) Nigam A, Ziv T, Oron-Gottesman A, Engelberg-Kulka H. Stress-induced MazF-mediated proteins in Escherichia coli. mBio 2019;10(2).

(7) Nigam A, Kumar S, Engelberg-Kulka H. Quorum sensing extracellular death peptides enhance the endoribonucleolytic activities of mycobacterium tuberculosis MazF toxins. mBio 2018;9(3).

(8) Kumar S, Kolodkin-Gal I, Vesper O, Alam N, Schueler-Furman O, Moll I, et al. Escherichia coli quorum-sensing EDF, a peptide generated by novel multiple distinct mechanisms and regulated by trans-translation. mBio 2016;7(1).

(9) Oron-Gottesman A, Sauert M, Moll I, Engelberg-Kulka H. A stress-induced bias in the reading of the genetic code in Escherichia coli. mBio 2016;7(6).

(10) Kolodkin-Gal I, Verdiger R, Shlosberg-Fedida A, Engelberg-Kulka H. Erratum: A differential effect of E. coli toxin-antitoxin systems on cell death in liquid media and biofilm formation (PLoS ONE (2015) 10:10(e0140184) 10.1371/journal.pone.0140184). PLoS ONE 2015;10(10).

(11) Engelberg-Kulka H, Kumar S. Yet another way that phage λ manipulates its Escherichia coli host: λrexB is involved in the lysogenic-lytic switch. Mol Microbiol 2015;96(4):689-693.

(12) Zorzini V, Buts L, Schrank E, Sterckx YGJ, Respondek M, Engelberg-Kulka H, et al. Escherichia coli antitoxin MazE as transcription factor: Insights into MazE-DNA binding. Nucleic Acids Res 2015;43(2):1241-1256.

(13) Kalderon Z, Kumar S, Engelberg-Kulka H. The SOS response is permitted in Escherichia coli strains deficient in the expression of the mazEF pathway. PLoS ONE 2014;9(12).

(14) Kumar S, Engelberg-Kulka H. Quorum sensing peptides mediating interspecies bacterial cell death as a novel class of antimicrobial agents. Curr Opin Microbiol 2014;21:22-27.

(15) Erental A, Kalderon Z, Saada A, Smith Y, Engelberg-Kulka H. Apoptosis-Like Death, An extreme SOS response in Escherichia Coli. mBio 2014;5(4).

(16) Kumar S, Kolodkin-Gal I, Engelberg-Kulka H. Novel quorum-sensing peptides mediating interspecies bacterial cell death. mBio 2013;4(3).

(17) Moll I, Engelberg-Kulka H. Selective translation during stress in Escherichia coli. Trends Biochem Sci 2012;37(11):493-498.

(18) Erental A, Sharon I, Engelberg-Kulka H. Two programmed cell death systems in escherichia coli: An apoptotic-like death is inhibited by the mazef-mediated death pathway. PloS Biol 2012;10(3).

(19) Vesper O, Amitai S, Belitsky M, Byrgazov K, Kaberdina AC, Engelberg-Kulka H, et al. Selective translation of leaderless mRNAs by specialized ribosomes generated by MazF in Escherichia coli. Cell 2011;147(1):147-157.

(20) Belitsky M, Avshalom H, Erental A, Yelin I, Kumar S, London N, et al. The Escherichia coli Extracellular Death Factor EDF Induces the Endoribonucleolytic Activities of the Toxins MazF and ChpBK. Mol Cell 2011;41(6):625-635.

(21) Kolodkin-Gal I, Verdinger R, Shlosberg-Fedida A, Engelberg-Kulka H. A differential effect of E. coli toxin-antitoxin systems on cell death in liquid media and biofilm formation. PLoS ONE 2009;4(8).

(22) Engelberg-Kulka H, Kolodkin-Gal I. The stationary-phase sigma factor σS is responsible for the resistance of Escherichia coli stationary-phase cells to mazEF-Mediated cell death. J Bacteriol 2009;191(9):3177-3182.

(23) Engelberg-Kulka H, Yelin I, Kolodkin-Gal I. Activation of a built-in bacterial programmed cell death system as a novel mechanism of action of some antibiotics. Commun Integr Biol 2009;2(3):211-212.

(24) Kolodkin-Gal I, Sat B, Keshet A, Engelberg-Kulka H. The communication factor EDF and the toxin-antitoxin module mazEF determine the mode of action of antibiotics. PloS Biol 2008;6(12):2774-2785.

(25) Kolodkin-Gal I, Engelberg-Kulka H. The extracellular death factor: Physiological and genetic factors influencing its production and response in Escherichia coli. J Bacteriol 2008;190(9):3169-3175.

(26) Kolodkin-Gal I, Hazan R, Gaathon A, Carmeli S, Engelberg-Kulka H. A linear pentapeptide is a quorum-sensing factor required for mazEF-mediated cell death in Escherichia coli. Science 2007;318(5850):652-655.

(27) Engelberg-Kulka H, Amitai S, Kolodkin-Gal I, Hazan R. Bacterial programmed cell death and multicellular behavior in bacteria. PLoS Genet 2006;2(10):1518-1526.

(28) Kolodkin-Gal I, Engelberg-Kulka H. Induction of Escherichia coli chromosomal mazEF by stressful conditions causes an irreversible loss of viability. J Bacteriol 2006;188(9):3420-3423.

(29) Engelberg-Kulka H, Hazan R, Amitai S. mazEF: A chromosomal toxin-antitoxin module that triggers programmed cell death in bacteria. J Cell Sci 2005;118(19):4327-4332.

(30) Lah J, Šimić M, Vesnaver G, Marianovsky I, Glaser G, Engelberg-Kulka H, et al. Energetics of structural transitions of the addiction antitoxin MazE: Is a programmed bacterial cell death dependent on the intrinsically flexible nature of the antitoxins. J Biol Chem 2005;280(17):17397-17407.

(31) Amitai S, Yassin Y, Engelberg-Kulka H. MazF-mediated cell death in Escherichia coli: A point of no return. J Bacteriol 2004;186(24):8295-8300.

(32) Hazan R, Engelberg-Kulka H. Escherichia coli mazEF-mediated cell death as a defense mechanism that inhibits the spread of phage P1. Mol Genet Genomics 2004;272(2):227-234.

(33) Hazan R, Sat B, Engelberg-Kulka H. Escherichia coli mazEF-mediated cell death is triggered by various stressful conditions. J Bacteriol 2004;186(11):3663-3669.

(34) Engelberg-Kulka H, Sat B, Reches M, Amitai S, Hazan R. Bacterial programmed cell death systems as targets for antibiotics. Trends Microbiol 2004;12(2):66-71.

(35) Engelberg-Kulka H, Hazan R. Cannibals defy starvation and avoid sporulation. Science 2003;301(5632):467-468.

(36) Loris R, Marianovsky I, Lah J, Laeremans T, Engelberg-Kulka H, Glaser G, et al. Crystal structure of the intrinsically flexible addiction antidote MazE. J Biol Chem 2003;278(30):28252-28257.

(37) Lah J, Marianovsky I, Glaser G, Engelberg-Kulka H, Kinne J, Wyns L, et al. Recognition of the intrinsically flexible addiction antidote MazE by a dromedary single domain antibody fragment: Structure, thermodynamics of binding, stability, and influence on interactions with DNA. J Biol Chem 2003;278(16):14101-14111.

(38) Sat B, Reches M, Engelberg-Kulka H. The Escherichia coli mazEF suicide module mediates thymineless death. J Bacteriol 2003;185(6):1803-1807.

(39) Hazan R, Sat B, Reches M, Engelberg-Kulka H. Postsegregational killing mediated by the P1 phage "addiction module" phd-doc requires the Escherichia coli programmed cell death system mazEF. J Bacteriol 2001;183(6):2046-2050.

(40) Sat B, Hazan R, Fisher T, Khaner H, Glaser G, Engelberg-Kulka H. Programmed cell death in Escherichia coli: Some antibiotics can trigger mazEF lethality. J Bacteriol 2001;183(6):2041-2045.

(41) Marianovsky I, Aizenman E, Engelberg-Kulka H, Glaser G. The Regulation of the Escherichia coli mazEF Promoter Involves an Unusual Alternating Palindrome. J Biol Chem 2001;276(8):5975-5984.

(42) Engelberg-Kulka H, Liu Z, Li C, Reches M. An extended Escherichia coli "selenocysteine insertion sequence" (SECIS) as a multifunctional RNA structure. Biofactors 2001;14(1-4):61-68.

(43) Li C, Reches M, Engelberg-Kulka H. The bulged nucleotide in the Escherichia coli minimal selenocysteine insertion sequence participates in interaction with SelB: A genetic approach. J Bacteriol 2000;182(22):6302-6307.

(44) Liu Z, Reches M, Engelberg-Kulka H. A sequence in the Escherichia coli fdhF 'selenocysteine insertion sequence' (SECIS) operates in the absence of selenium. J Mol Biol 1999;294(5):1073-1086.

(45) Engelberg-Kulka H, Glaser G. Addiction modules and programmed cell death and antideath in bacterial cultures. Annu Rev Microbiol 1999;53:43-70.

(46) Engelberg-Kulka H, Reches M, Narasimhan S, Schoulaker-Schwarz R, Klemes Y, Aizenman E, et al. rexB of bacteriophage λ is an anti-cell death gene. Proc Natl Acad Sci U S A 1998;95(26):15481-15486.

(47) Liu Z, Reches M, Groisman I, Engelberg-Kulka H. The nature of the minimal 'selenocysteine insertion sequence' (SECIS) in Escherichia coli. Nucleic Acids Res 1998;26(4):896-902.

(48) Chen Q, Engelberg-Kulka H, Amster-Choder O. The localization of the phosphorylation site of BglG, the response regulator of the Escherichia coli bgl sensory system. J Biol Chem 1997;272(28):17263-17268.

(49) Liu Z, Reches M, Engelberg-Kulka H. A rapid fluorescence bioassay for the determination of selenium on agar plates. Anal Biochem 1997;244(1):40-44.

(50) Aizenman E, Engelberg-Kulka H, Glaser G. An Escherichia coli chromosomal "addiction module" regulated by 3′,5′-bispyrophosphate: A model for programmed bacterial cell death. Proc Natl Acad Sci U S A 1996;93(12):6059-6063.

(51) Aizenman E, Engelberg-Kulka H, Glaser G. Erratum: An Escherichia coli chromosomal 'addiction module' regulated by 3',5'-bispyrophosphate: A model for programmed bacterial cell death (Proceedings of the National Academy of Sciences of the United States of America (June 11, 1996) 93:12 (6059-6063)). Proc Natl Acad Sci U S A 1996;93(18):9991.

(52) Groisman I, Engelberg-Kulka H. Translational bypassing: a new reading alternative of the genetic code. Biochem Cell Biol 1995;73(11-12):1055-1059.

(53) Zhao C, Reches M, Depalo D, St. Germain DL, Engelberg-Kulka H. A recombinant DNA bio-assay for selenium in blood. Gene 1994;148(2):351-356.

(54) Engelberg‐Kulka H, Schoulaker‐Schwarz R. Regulatory implications of translational frameshifting in cellular gene expression. Mol Microbiol 1994;11(1):3-8.

(55) Goldman-Levi R, Kopelowitz J, Engelberg-Kulka H. The nature of the nucleotide at the 5′ side of the tRNA Su9 anticodon affects UGA suppression in Escherichia coli. DNA Res 1994;1(3):123-127.

(56) Reches M, Zhao C, Engelberg-Kulka H. A bioassay based on recombinant DNA technology for determining selenium concentration. Appl Environ Microbiol 1994;60(1):45-50.

(57) DePalo D, Kinlaw WB, Zhao C, Engelberg-Kulka H, St. Germain DL. Effect of selenium deficiency on type I 5'-deiodinase. J Biol Chem 1994;269(23):16223-16228.

(58) Benhar I, Engelberg-Kulka H. Frameshifting in the expression of the E. coli trpR gene occurs by the bypassing of a segment of its coding sequence. Cell 1993;72(1):121-130.

(59) Engelberg-Kulka H, Benhar I, Schoulaker-Schwarz R. Translational introns: an additional regulatory element in gene expression. Trends Biochem Sci 1993;18(8):294-296.

(60) Benhar I, Miller C, Engelberg-Kulka H. Frameshifting in the expression of the Escherichia coli trpR gene is modulated by translation initiation. J Bacteriol 1993;175(10):3204-3207.

(61) Bejarano I, Klemes Y, Schoulaker-Schwarz R, Engelberg-Kulka H. Energy-dependent degradation of λO protein in Escherichia coli. J Bacteriol 1993;175(23):7720-7723.

(62) Kopelowitz J, Hampe C, Goldman R, Reches M, Engelberg-Kulka H. Influence of codon context on UGA suppression and readthrough. J Mol Biol 1992;225(2):261-269.

(63) Benhar I, Miller C, Engelberg‐Kulka H. Frameshifting in the expression of the Escherichia coli trpR gene. Mol Microbiol 1992;6(19):2777-2784.

(64) Benhar I, Engelberg-Kulka H. A procedure for amino acid sequencing in internal regions of proteins. Gene 1991;103(1):79-82.

(65) Schoulaker-Schwarz R, Dekel-Gorodetsky L, Engelberg-Kulka H. An additional function for bacteriophage λ rex: The rexB product prevents degradation of the λ O protein. Proc Natl Acad Sci U S A 1991;88(11):4996-5000.

(66) Engelberg-Kulka H, Schoulaker-Schwarz R. Stop is not the end: Physiological implications of translational readthrough. J Theor Biol 1988;131(4):477-485.

(67) Engelberg-Kulka H, Schoulaker-Schwarz R. A flexible genetic code, or why does selenocysteine have no unique codon? Trends Biochem Sci 1988;13(11):419-421.

(68) Dekel-Gorodetsky L, Schoulaker-Schwarz R, Engelberg-Kulka H. Escherichia coli tryptophan operon directs the in vivo synthesis of a leader peptide. J Bacteriol 1986;165(3):1046-1048.

(69) Kopelowitz J, Schoulaker-Schwarz R, Lebanon A, Engelberg-Kulka H. Modulation of Escherichia coli tryptophan (trp) attenuation by the UGA readthrough process. Molec Gen Genet 1984;196(3):541-545.

(70) Schoulaker-Schwarz R, Engelberg-Kulka H. Effect of an Escherichia coli traD (ts) mutation on MS2 RNA replication. J Gen Virol 1983;64 (Pt 1):207-210.

(71) Engelberg-Kulka H, Amiel A, Miller C, Schoulaker-Schwarz R. Studies on the involvement of the UGA readthrough process in the mechanism of attenuation of the tryptophan operon of Escherichia coli. Molec Gen Genet 1982;188(1):156-160.

(72) Engelberg-Kulka H, Amiel A, Dekel L, Raveh B, Schoulaker-Schwarz R. Genetic analysis of a streptomycin-resistant Escherichia coli mutant temperature-sensitive for nonsense suppression. Molec Gen Genet 1982;188(1):149-155.

(73) Engelberg-Kulka H, Dekel L, Israeli-Reches M. Regulation of the Escherichia coli tryptophan operon by readthrough of UGA termination codons. Biochem Biophys Res Commun 1981;98(4):1008-1015.

(74) Engelberg-Kulka H. UGA suppression by normal tRNATrP in Escherichia coli: Codon context effects. Nucleic Acids Res 1981;9(4):983-991.

(75) Schoulaker-Schwarz R, Engelberg-Kulka H. Escherichia coli traD(Ts) mutant temperature sensitive for assembly of RNA bacteriophage MS2. J Virol 1981;38(3):833-839.

(76) Zeevi M, Daniel V, Engelberg-Kulka H. A streptomycin-resistant Escherichia coli mutant with ribosomes temperature-sensitive in the suppression of a nonsense codon. Molec gen Genet 1979;170(2):149-153.

(77) Engelberg-Kulka H, Israeli-Reches M, Dekel L, Friedmann A. Qβ-Defective particles produced in a streptomycin-resistant Escherichia coli mutant. J Virol 1979;29(3):1107-1117.

(78) Engelberg-Kulka H, Dekel L, Israeli-Reches M, Belfort M. The requirement of nonsense suppression for the development of several phages. Molec gen Genet 1979;170(2):155-159.

(79) Schoulaker R, Engelberg-Kulka H. Escherichia coli mutant temperature sensitive for group I RNA bacteriophages. J Virol 1978;25(1):433-435.

(80) Engelberg Kulka H, Dekel L, Israeli Reches M. Streptomycin resistant Escherichia coli mutant temperature sensitive for the production of Qβ infective particles. J Virol 1977;21(1):1-6.